{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:29:37Z","timestamp":1793690977986,"version":"4.5.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,11]]},"DOI":"10.7759\/cureus.45009","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T04:22:09Z","timestamp":1694406129000},"source":"Crossref","is-referenced-by-count":1,"title":["Closing the Gap: Investigation of Various Approaches in the Management of Patent Ductus Arteriosus"],"prefix":"10.7759","author":[{"given":"Farhana","family":"Ghouse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Idrobo Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan K","family":"Kasam Shiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rithika","family":"Siripragada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliano","family":"Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5863\/1551-6776-12.3.138","article-title":"Patent ductus arteriosus: an overview","volume":"12","author":"Dice JE","year":"2007","unstructured":"Dice JE, Bhatia J. Patent ductus arteriosus: an overview. J Pediatr Pharmacol Ther. 2007, 12:138-46. 10.5863\/1551-6776-12.3.138","journal-title":"J Pediatr Pharmacol Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-022-05387-7","article-title":"Ductus arteriosus: more than just the patent ductus arteriosus","volume":"52","author":"Buckland CC","year":"2022","unstructured":"Buckland CC, Potts JE, Mawson JB, Culham JA. Ductus arteriosus: more than just the patent ductus arteriosus. Pediatr Radiol. 2022, 52:1426-36. 10.1007\/s00247-022-05387-7","journal-title":"Pediatr Radiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232213877","article-title":"The association of patent ductus arteriosus with inflammation: a narrative review of the role of inflammatory biomarkers and treatment strategy in premature infants","volume":"23","author":"Wei YJ","year":"2022","unstructured":"Wei YJ, Hsu R, Lin YC, Wong TW, Kan CD, Wang JN. The association of patent ductus arteriosus with inflammation: a narrative review of the role of inflammatory biomarkers and treatment strategy in premature infants. Int J Mol Sci. 2022, 23:10.3390\/ijms232213877","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.47391\/JPMA.3416","article-title":"Outcomes of preterm neonates with patent ductus arteriosus: A retrospective review from a tertiary care hospital","volume":"72","author":"Khowaja W","year":"2022","unstructured":"Khowaja W, Akhtar S, Jiwani U, Mohsin M, Shaheen F, Ariff S. Outcomes of preterm neonates with patent ductus arteriosus: A retrospective review from a tertiary care hospital. J Pak Med Assoc. 2022, 72:2065-8. 10.47391\/JPMA.3416","journal-title":"J Pak Med Assoc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-1209","article-title":"Patent ductus arteriosus of the preterm infant","volume":"146","author":"Hamrick SE","year":"2020","unstructured":"Hamrick SE, Sallmon H, Rose AT, Porras D, Shelton EL, Reese J, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics. 2020, 146:10.1542\/peds.2020-1209","journal-title":"Pediatrics"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2010.3","article-title":"Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?","volume":"30","author":"Benitz WE","year":"2010","unstructured":"Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?. J Perinatol. 2010, 30:241-52. 10.1038\/jp.2010.3","journal-title":"J Perinatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3730","article-title":"Patent ductus arteriosus in preterm infants","volume":"137","author":"Benitz WE","year":"2016","unstructured":"Benitz WE. Patent ductus arteriosus in preterm infants. Pediatrics. 2016, 137:10.1542\/peds.2015-3730","journal-title":"Pediatrics"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.1896","article-title":"Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis","volume":"319","author":"Mitra S","year":"2018","unstructured":"Mitra S, Florez ID, Tamayo ME, et al.. Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. JAMA. 2018, 319:1221-38. 10.1001\/jama.2018.1896","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2020.10.035","article-title":"Percutaneous closure of patent ductus arteriosus in infants 1.5 kg or less: a meta-analysis","volume":"230","author":"Bischoff AR","year":"2021","unstructured":"Bischoff AR, Jasani B, Sathanandam SK, Backes C, Weisz DE, McNamara PJ. Percutaneous closure of patent ductus arteriosus in infants 1.5 kg or less: a meta-analysis. J Pediatr. 2021, 230:84-92. 10.1016\/j.jpeds.2020.10.035","journal-title":"J Pediatr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(83)80736-7","article-title":"Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus","volume":"103","author":"Seyberth HW","year":"1983","unstructured":"Seyberth HW, Rascher W, Hackenthal R, Wille L. Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus. J Pediatr. 1983, 103:979-84. 10.1016\/s0022-3476(83)80736-7","journal-title":"J Pediatr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010061.pub4","article-title":"Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants","volume":"1","author":"Ohlsson A","year":"2020","unstructured":"Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev. 2020, 1:10.1002\/14651858.CD010061.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1055\/a-1782-5860","article-title":"Randomized noninferiority trial of expectant management versus early treatment of patent ductus arteriosus in preterm infants","author":"Potsiurko S","year":"2022","unstructured":"Potsiurko S, Dobryanskyy D, Sekretar L, Salabay Z. Randomized noninferiority trial of expectant management versus early treatment of patent ductus arteriosus in preterm infants. Am J Perinatol. 2022, 10.1055\/a-1782-5860","journal-title":"Am J Perinatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2207418","article-title":"Expectant management or early ibuprofen for patent ductus arteriosus","volume":"388","author":"Hundscheid T","year":"2023","unstructured":"Hundscheid T, Onland W, Kooi EM, et al.. Expectant management or early ibuprofen for patent ductus arteriosus. N Engl J Med. 2023, 388:980-90. 10.1056\/NEJMoa2207418","journal-title":"N Engl J Med"},{"key":"ref14","article-title":"Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants","author":"Mosalli R","year":"2008","unstructured":"Mosalli R, Alfaleh K. Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants. Cochrane Database Syst Rev. 2008, 2008:Accessed: August 20, 2023: http:\/\/10.1002\/14651858.CD006181.pub2."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1090594","article-title":"The ductus arteriosus rarely requires treatment in infants > 1000 grams","volume":"25","author":"Nemerofsky SL","year":"2008","unstructured":"Nemerofsky SL, Parravicini E, Bateman D, Kleinman C, Polin RA, Lorenz JM. The ductus arteriosus rarely requires treatment in infants > 1000 grams. Am J Perinatol. 2008, 25:661-6. 10.1055\/s-0028-1090594","journal-title":"Am J Perinatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1542\/neo.19-7-e394","article-title":"Diagnosis and management of patent ductus arteriosus","volume":"19","author":"Gillam-Krakauer M","year":"2018","unstructured":"Gillam-Krakauer M, Reese J. Diagnosis and management of patent ductus arteriosus. Neoreviews. 2018, 19:394-402. 10.1542\/neo.19-7-e394","journal-title":"Neoreviews"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2023.07.007","article-title":"Expectant management of patent ductus arteriosus for preterm infants: a meta-analysis of randomized controlled trials","author":"Cheema HA","year":"2023","unstructured":"Cheema HA, Majeed Z, Hayat T, et al.. Expectant management of patent ductus arteriosus for preterm infants: a meta-analysis of randomized controlled trials. Am Heart J. 2023, 10.1016\/j.ahj.2023.07.007","journal-title":"Am Heart J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.626261","article-title":"Conservative management of patent ductus arteriosus in preterm infants - a systematic review and meta-analyses assessing differences in outcome measures between randomized controlled trials and cohort studies","volume":"9","author":"Hundscheid T","year":"2021","unstructured":"Hundscheid T, Jansen EJ, Onland W, Kooi EM, Andriessen P, de Boode WP. Conservative management of patent ductus arteriosus in preterm infants - a systematic review and meta-analyses assessing differences in outcome measures between randomized controlled trials and cohort studies. Front Pediatr. 2021, 9:10.3389\/fped.2021.626261","journal-title":"Front Pediatr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S1084-2756(03)00121-0","article-title":"Treatment of patent ductus arteriosus","volume":"8","author":"Wyllie J","year":"2003","unstructured":"Wyllie J. Treatment of patent ductus arteriosus. Semin Neonatol. 2003, 8:425-32. 10.1016\/S1084-2756(03)00121-0","journal-title":"Semin Neonatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211895","article-title":"Fluid regimens in the first week of life may increase risk of patent ductus arteriosus in extremely low birth weight infants","volume":"28","author":"Stephens BE","year":"2008","unstructured":"Stephens BE, Gargus RA, Walden RV, et al.. Fluid regimens in the first week of life may increase risk of patent ductus arteriosus in extremely low birth weight infants. J Perinatol. 2008, 28:123-8. 10.1038\/sj.jp.7211895","journal-title":"J Perinatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2012.03.012","article-title":"Hemodynamic effects of fluid restriction in preterm infants with significant patent ductus arteriosus","volume":"161","author":"De Buyst J","year":"2012","unstructured":"De Buyst J, Rakza T, Pennaforte T, Johansson AB, Storme L. Hemodynamic effects of fluid restriction in preterm infants with significant patent ductus arteriosus. J Pediatr. 2012, 161:404-8. 10.1016\/j.jpeds.2012.03.012","journal-title":"J Pediatr"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2009.60","article-title":"Effects of low oxygen saturation limits on the ductus arteriosus in extremely low birth weight infants","volume":"29","author":"Noori S","year":"2009","unstructured":"Noori S, Patel D, Friedlich P, Siassi B, Seri I, Ramanathan R. Effects of low oxygen saturation limits on the ductus arteriosus in extremely low birth weight infants. J Perinatol. 2009, 29:553-7. 10.1038\/jp.2009.60","journal-title":"J Perinatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198303313081303","article-title":"Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome","volume":"308","author":"Green TP","year":"1983","unstructured":"Green TP, Thompson TR, Johnson DE, Lock JE. Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome. N Engl J Med. 1983, 308:743-8. 10.1056\/NEJM198303313081303","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001148","article-title":"Furosemide for prevention of morbidity in indomethacin\u2010treated infants with patent ductus arteriosus","volume":"2001","author":"Brion LP","year":"2001","unstructured":"Brion LP, Campbell D. Furosemide for prevention of morbidity in indomethacin\u2010treated infants with patent ductus arteriosus. Cochrane Database Syst Rev. 2001, 2001:10.1002\/14651858.CD001148","journal-title":"Cochrane Database Syst Rev"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2004.10.003","article-title":"The pharmacologic closure of the patent ductus arteriosus","volume":"10","author":"Van Overmeire B","year":"2005","unstructured":"Van Overmeire B, Chemtob S. The pharmacologic closure of the patent ductus arteriosus. Semin Fetal Neonatal Med. 2005, 10:177-84. 10.1016\/j.siny.2004.10.003","journal-title":"Semin Fetal Neonatal Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(83)80022-5","article-title":"Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study","volume":"102","author":"Gersony WM","year":"1983","unstructured":"Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr. 1983, 102:895-906. 10.1016\/s0022-3476(83)80022-5","journal-title":"J Pediatr"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-013-0031-7","article-title":"Clinical pharmacology of indomethacin in preterm infants: implications in patent ductus arteriosus closure","volume":"15","author":"Pacifici GM","year":"2013","unstructured":"Pacifici GM. Clinical pharmacology of indomethacin in preterm infants: implications in patent ductus arteriosus closure. Paediatr Drugs. 2013, 15:363-76. 10.1007\/s40272-013-0031-7","journal-title":"Paediatr Drugs"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2007.11928244","article-title":"Ibuprofen lysine (NeoProfen) for the treatment of patent ductus arteriosus","volume":"20","author":"Poon G","year":"2007","unstructured":"Poon G. Ibuprofen lysine (NeoProfen) for the treatment of patent ductus arteriosus. Proc (Bayl Univ Med Cent). 2007, 20:83-5. 10.1080\/08998280.2007.11928244","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003481.pub8","article-title":"Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants","volume":"2","author":"Ohlsson A","year":"2020","unstructured":"Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database Syst Rev. 2020, 2:10.1002\/14651858.CD003481.pub8","journal-title":"Cochrane Database Syst Rev"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1438038","article-title":"Paracetamol in patent ductus arteriosus treatment: efficacious and safe?","volume":"2017","author":"Bardanzellu F","year":"2017","unstructured":"Bardanzellu F, Neroni P, Dess\u00ec A, Fanos V. Paracetamol in patent ductus arteriosus treatment: efficacious and safe?. Biomed Res Int. 2017, 2017:10.1155\/2017\/1438038","journal-title":"Biomed Res Int"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2014-307312","article-title":"Paracetamol for the treatment of patent ductus arteriosus in preterm neonates: a systematic review and meta-analysis","volume":"101","author":"Terrin G","year":"2016","unstructured":"Terrin G, Conte F, Oncel MY, et al.. Paracetamol for the treatment of patent ductus arteriosus in preterm neonates: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2016, 101:127-36. 10.1136\/archdischild-2014-307312","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1159\/000526318","article-title":"Comparison of various pharmacologic agents in the management of hemodynamically significant patent ductus arteriosus in preterm: a network meta-analysis and risk-benefit analysis","volume":"7","author":"Eursiriwan S","year":"2022","unstructured":"Eursiriwan S, Okascharoen C, Vallibhakara SA, Pattanaprateep O, Numthavaj P, Attia J, Thakkinstian A. Comparison of various pharmacologic agents in the management of hemodynamically significant patent ductus arteriosus in preterm: a network meta-analysis and risk-benefit analysis. Biomed Hub. 2022, 7:125-45. 10.1159\/000526318","journal-title":"Biomed Hub"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002923","article-title":"Percutaneous patent ductus arteriosus (PDA) closure in very preterm infants: feasibility and complications","volume":"5","author":"Backes CH","year":"2016","unstructured":"Backes CH, Cheatham SL, Deyo GM, et al.. Percutaneous patent ductus arteriosus (PDA) closure in very preterm infants: feasibility and complications. J Am Heart Assoc. 2016, 5:10.1161\/JAHA.115.002923","journal-title":"J Am Heart Assoc"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2010.08.022","article-title":"Outcomes of transcatheter occlusion of patent ductus arteriosus in infants weighing \u22646 kg","volume":"3","author":"Dimas VV","year":"2010","unstructured":"Dimas VV, Takao C, Ing FF, et al.. Outcomes of transcatheter occlusion of patent ductus arteriosus in infants weighing \u22646 kg. JACC Cardiovasc Interv. 2010, 3:1295-9. 10.1016\/j.jcin.2010.08.022","journal-title":"JACC Cardiovasc Interv"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2010.01.016","article-title":"Transcatheter occlusion of patent ductus arteriosus in pre-term infants","volume":"3","author":"Francis E","year":"2010","unstructured":"Francis E, Singhi AK, Lakshmivenkateshaiah S, Kumar RK. Transcatheter occlusion of patent ductus arteriosus in pre-term infants. JACC Cardiovasc Interv. 2010, 3:550-5. 10.1016\/j.jcin.2010.01.016","journal-title":"JACC Cardiovasc Interv"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2021.06.005","article-title":"Echocardiographic versus angiographic measurement of the patent ductus arteriosus in extremely low birth weight infants and the utility of echo guidance for transcatheter closure","volume":"34","author":"Paudel G","year":"2021","unstructured":"Paudel G, Johnson JN, Philip R, et al.. Echocardiographic versus angiographic measurement of the patent ductus arteriosus in extremely low birth weight infants and the utility of echo guidance for transcatheter closure. J Am Soc Echocardiogr. 2021, 34:1086-94. 10.1016\/j.echo.2021.06.005","journal-title":"J Am Soc Echocardiogr"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-020-02357-4","article-title":"Accessing femoral arteries less than 3\u00a0mm in diameter is associated with increased incidence of loss of pulse following cardiac catheterization in infants","volume":"41","author":"Tadphale S","year":"2020","unstructured":"Tadphale S, Yohannan T, Kauffmann T, et al.. Accessing femoral arteries less than 3\u00a0mm in diameter is associated with increased incidence of loss of pulse following cardiac catheterization in infants. Pediatr Cardiol. 2020, 41:1058-66. 10.1007\/s00246-020-02357-4","journal-title":"Pediatr Cardiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivv185","article-title":"Is thoracoscopic patent ductus arteriosus closure superior to conventional surgery?","volume":"21","author":"Stankowski T","year":"2015","unstructured":"Stankowski T, Aboul-Hassan SS, Marczak J, Cichon R. Is thoracoscopic patent ductus arteriosus closure superior to conventional surgery?. Interact Cardiovasc Thorac Surg. 2015, 21:532-8. 10.1093\/icvts\/ivv185","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2006.04.040","article-title":"Comparison of suture ligation and clip application for the treatment of patent ductus arteriosus in preterm neonates","volume":"132","author":"Mandhan PL","year":"2006","unstructured":"Mandhan PL, Samarakkody U, Brown S, Kukkady A, Maoate K, Blakelock R, Beasley S. Comparison of suture ligation and clip application for the treatment of patent ductus arteriosus in preterm neonates. J Thorac Cardiovasc Surg. 2006, 132:672-4. 10.1016\/j.jtcvs.2006.04.040","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1177\/2150135118766454","article-title":"Surgical closure of patent ductus arteriosus in premature neonates weighing less than 1,000 grams: contemporary outcomes","volume":"9","author":"Lehenbauer DG","year":"2018","unstructured":"Lehenbauer DG, Fraser CD 3rd, Crawford TC, et al.. Surgical closure of patent ductus arteriosus in premature neonates weighing less than 1,000 grams: contemporary outcomes. World J Pediatr Congenit Heart Surg. 2018, 9:419-23. 10.1177\/2150135118766454","journal-title":"World J Pediatr Congenit Heart Surg"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1001\/archoto.2007.2","article-title":"Unilateral vocal cord paralysis following patent ductus arteriosus ligation in extremely low-birth-weight infants","volume":"134","author":"Clement WA","year":"2008","unstructured":"Clement WA, El-Hakim H, Phillipos EZ, Cot\u00e9 JJ. Unilateral vocal cord paralysis following patent ductus arteriosus ligation in extremely low-birth-weight infants. Arch Otolaryngol Head Neck Surg. 2008, 134:28-33. 10.1001\/archoto.2007.2","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-012-1787-4","article-title":"Diaphragmatic paralysis among very low birth weight infants following ligation for patent ductus arteriosus","volume":"171","author":"Hsu KH","year":"2012","unstructured":"Hsu KH, Chiang MC, Lien R, et al.. Diaphragmatic paralysis among very low birth weight infants following ligation for patent ductus arteriosus. Eur J Pediatr. 2012, 171:1639-44. 10.1007\/s00431-012-1787-4","journal-title":"Eur J Pediatr"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2019.10.002","article-title":"Therapeutic strategy of patent ductus arteriosus in extremely preterm infants","volume":"61","author":"Su BH","year":"2020","unstructured":"Su BH, Lin HY, Chiu HY, Tsai ML, Chen YT, Lu IC. Therapeutic strategy of patent ductus arteriosus in extremely preterm infants. Pediatr Neonatol. 2020, 61:133-41. 10.1016\/j.pedneo.2019.10.002","journal-title":"Pediatr Neonatol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1097\/ANC.0000000000000340","article-title":"Patent ductus arteriosus in the preterm infant: diagnostic and treatment options","volume":"17","author":"Prescott S","year":"2017","unstructured":"Prescott S, Keim-Malpass J. Patent ductus arteriosus in the preterm infant: diagnostic and treatment options. Adv Neonatal Care. 2017, 17:10-8. 10.1097\/ANC.0000000000000340","journal-title":"Adv Neonatal Care"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198203043060903","article-title":"Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants","volume":"306","author":"Mahony L","year":"1982","unstructured":"Mahony L, Carnero V, Brett C, Heymann MA, Clyman RI. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. N Engl J Med. 1982, 306:506-10. 10.1056\/NEJM198203043060903","journal-title":"N Engl J Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2011.12.031","article-title":"Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial","volume":"160","author":"Sosenko IR","year":"2012","unstructured":"Sosenko IR, Fajardo MF, Claure N, Bancalari E. Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial. J Pediatr. 2012, 160:929-35. 10.1016\/j.jpeds.2011.12.031","journal-title":"J Pediatr"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1159\/000367887","article-title":"Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants","volume":"107","author":"Gudmundsdottir A","year":"2015","unstructured":"Gudmundsdottir A, Johansson S, H\u00e5kansson S, Norman M, K\u00e4llen K, Bonamy AK. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants. Neonatology. 2015, 107:87-92. 10.1159\/000367887","journal-title":"Neonatology"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000174.pub2","article-title":"Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants","volume":"2010","author":"Fowlie PW","year":"2010","unstructured":"Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev. 2010, 2010:10.1002\/14651858.CD000174.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013588.pub2","article-title":"Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews","volume":"4","author":"Mitra S","year":"2023","unstructured":"Mitra S, de Boode WP, Weisz DE, Shah PS. Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews. Cochrane Database Syst Rev. 2023, 4:10.1002\/14651858.CD013588.pub2","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/184497-closing-the-gap-investigation-of-various-approaches-in-the-management-of-patent-ductus-arteriosus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:04:26Z","timestamp":1793689466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/184497-closing-the-gap-investigation-of-various-approaches-in-the-management-of-patent-ductus-arteriosus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":49,"URL":"https:\/\/doi.org\/10.7759\/cureus.45009","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,11]]}}}